Kristy Ainslie/pharmacy.unc.edu
Mar 6, 2026, 15:43
Kristy Ainslie: Breaking Down the Discovery and FDA Approval of Drug Carriers
Kristy Ainslie, Fred Eshelman Distinguished Professor and Director at University of North Carolina at Chapel Hill, shared a post on LinkedIn:
“Ever wonder about the discovery and FDA approval of your favorite drug carrier? I’ve broken them down and highlighted each advancement – with references!
Enjoy and let me know if think I forgot something.
Part 1 – Living Medicine
Part 2 – Complex Biologics
Part 3 – Inorganic Carriers
Part 4 – Other Carriers
Part 5 – Nucleic Acids and Lipids
Part 6 – Polymers
Part 7 – Proteins
Part 8 – Devices”
Stay updated with Hemostasis Today.
-
Apr 15, 2026, 08:51Moustafa Abdou: Sutimlimab is Transforming Outcomes in Cold Agglutinin Disease
-
Apr 15, 2026, 04:52Ulrich Pecks: Personalized Approaches to VTE Prevention in Pregnant Women with Inherited Thrombophilia
-
Apr 15, 2026, 04:06Brenda Pleasant: Insights from the HFA Symposium on Hemophilia Care
-
Apr 15, 2026, 03:43Lexy Halloran: Addressing Diagnostic Inequities in Women with Chronic Conditions
-
Apr 14, 2026, 17:32Denise M.: Surviving Sepsis 2026 – The Upstream Revolution
-
Apr 14, 2026, 17:23Meghanath Yenni։ What’s New in Acute Ischemic Stroke in 2026
-
Apr 14, 2026, 17:11Phil Spinella: What Dose of TXA for Children With Severe Traumatic Bleeding Should You Use?
-
Apr 14, 2026, 17:08Abdulrahman Katib: How Endovascular Stenting Is Transforming the Treatment of Severe PTS
-
Apr 14, 2026, 17:00Anna A. Avagyan: Glad to Be Part of EHA Pediatric Hematology-Oncology Course